(5.10) Adverse Reactions/Side Effects The most common adverse reactions, reported in 5% of patients treated with MOUNJARO are nausea, diarrhea, decreased appetite, vomiting, constipation, dyspepsia, and abdominal pain
What that framing leaves out is scale: the article says the appetite suppression and weight loss produced by GLP-1 agonists far exceed berberine's more modest metabolic improvements
That is biology doing exactly what biology does when you remove a GLP-1 receptor agonist from the equation
A Little Analogy As a way of parsing the controversy surrounding these medications, I think it helps to view them as analogous to antidepressants, like Prozac, Lexapro, or Wellbutrin
Lifestyle and Condition Coaching (LCC) Program: Weight Management Coaching It can be challenging to recognize behaviors that make it difficult to keep a healthy weight